Home > Insider Trading > Filing (0000313143-14-000024)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1457882	Jonathan White	400 Wood Road Braintree MA 02184	Chief Science And Technology	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-02-07	700	$38.66	26,346	No	4	S	Direct
Common Stock	Disposition	2014-02-07	315	$38.67	26,031	No	4	S	Direct
Common Stock	Disposition	2014-02-07	865	$38.66	25,166	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$26.47	2010-10-27	2016-10-27	24,484	24,484	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$27.50	2011-10-27	2017-10-27	30,776	30,776	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$30.03	2010-01-28	2016-01-28	35,282	35,282	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$30.67	2012-10-25	2018-10-25	35,130	35,130	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$33.93	2012-07-20	2018-07-20	27,948	27,948	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$39.06	2013-10-24	2019-10-24	32,192	32,192	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$41.66	2014-10-23	2019-10-23	28,523	28,523	Direct
Common Stock	Performance Shares	$0.00	2017-03-31	2017-12-31	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-10-27	24,484	24,484	Direct
2017-10-27	30,776	30,776	Direct
2016-01-28	35,282	35,282	Direct
2018-10-25	35,130	35,130	Direct
2018-07-20	27,948	27,948	Direct
2019-10-24	32,192	32,192	Direct
2019-10-23	28,523	28,523	Direct
2017-12-31	25,000	25,000	Direct

Footnotes

Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).